The price take-down is a last desperate attempt be
Post# of 72440
Unlike most other small biotechs, we have multiple completely different drugs in development. Any one of them having good results in their current phase would justify a price of 10-20/share.
Why else do you think such a huge effort is being made to try to scare people out of this stock?